'We are firing on all cylinders': Bayer pharma BD chief says group overhaul not slowing dealmaking

[cafead]

via At Bayer, a groupwide restructuring is being rolled out as a top priority. But, to Juergen Eckhardt, M.D., who leads both the investment arm Leaps by Bayer and the pharma business development team, the ongoing overhaul won’t disrupt the German company’s dealmaking appetite.

article source